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Abstract
Introduction: Pleural effusion secondary to ventriculoperitoneal shunt insertion is a rare and
potentially life-threatening occurrence.
Case presentation: We describe a 14-month-old Caucasian boy who had a ventriculoperitoneal
shunt inserted for progressive hydrocephalus of unknown etiology. Two and a half months post-shunt
insertion, the patient presented with mild respiratory distress. A chest radiograph revealed a large
right pleural effusion and a shunt series demonstrated an appropriately placed distal catheter tip. A
subsequent abdominal ultrasound revealed marked ascites. Fluid drained via tube thoracostomy was
sent for beta-2-transferrin electrophoresis. A positive test was highly suggestive of cerebral spinal
fluid hydrothorax. Post-externalization of the ventriculoperitoneal shunt, the ascites and pleural
effusion resolved.
Conclusion: Testing for beta-2-transferrin protein in pleural fluid may serve as a useful technique
for diagnosing cerebrospinal fluid hydrothorax in patients with ventriculoperitoneal shunts.
Introduction
Mechanical shunting of cerebrospinal fluid (CSF) is an
effective treatment for non-obstructive hydrocephalus. In
particular, ventriculoperitoneal (VP) shunting has become
a preferred method in most clinical centers. Despite the
wide acceptance of VP shunting, there are important
complications associated with this technique. Common
problems include obstruction, mechanical shunt failure
and infections [1] while CSF ascites and thoracic compli-
cations, such as CSF hydrothorax, are less frequently
observed sequelae [2]. Most cases of the lattermost
complication, CSF hydrothorax, occur secondary to
intrathoracic shunt tip migration [3]. However, a small
number of cases, mostly in the pediatric population and
secondary to massive ascites, have been reported with
normal shunt position [2].
We report a 14-month-old Caucasian boy with a sympto-
matic pleural effusion that developed two and a half
months post-VP shunt insertion for hydrocephalus of
unknown etiology. We will review potential mechanisms
behind the development of this complication and discuss
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hydrothorax in children with VP shunts.
Case presentation
A 14-month-old Caucasian boy with idiopathic non-
obstructive hydrocephalus and a VP shunt presented to the
emergency room with a 1-day history of mild respiratory
distress without cough or fever. The patient had presented
at 11 months of age with a history of enlarging head
circumference and developmental delay. A computed
tomography (CT) scan of his head at 11 months of age
revealed enlargement of the lateral, third and fourth
ventricles and a bulky choroid plexus. A right-sided
programmable valve VP shunt was inserted at that time.
On examination, the 14-month-old patient was found to
be afebrile and tachypneic (34 breaths/minute) with
mildly increased work of breathing and decreased
respiratory sounds in the distal aspect of the right lung.
The cardiovascular exam was within normal limits. An
examination of the abdomen revealed distension but no
hepatomegaly or signs of peritoneal irritation.
A chest radiograph (Figures 1 and 2) revealed a large right-
sided pleural effusion, which was confirmed by chest
ultrasonography to be a fluid collection measuring 12.3 ¥
9.2cm. A shunt series demonstrated the VP shunt to be in
place without signs of discontinuity or leakage.
At the time of admission, venous blood gas, serum
electrolytes and creatinine were within normal limits.
Blood urea nitrogen and white blood count were mildly
elevated at 5.1mmol/L and 12.5 ¥ 10
9/L, respectively.
Further blood work demonstrated an alanine aminotrans-
ferase (ALT) level of 46U/L, an aspartate aminotransferase
(AST) level of 51U/L, a serum calcium level of 2.61mmol/
L and an alkaline phosphatase (ALP) level of 1403U/L.
Subsequently, ALP steadily decreased to 498U/L but
remained elevated throughout the patient’s admission.
A thoracentesis was performed and a chest tube was
inserted which drained >300cc/day of clear, yellow fluid.
Around the time of chest tube insertion, the patient was
noted to have an increasing abdominal girth, sizeable
positive fluid balance and weight gain. An abdominal/
pelvic ultrasound revealed marked ascites. Structurally
normal major abdominal and pelvic viscera as well as
normal vena caval and hepatic venous flows were
reported.
A head CT showed no change from a previous scan carried
out at 11 months of age. A parallel pleural fluid and CSF
analysis was also performed which is detailed in Table 1.
Secondary to the discordance between the white cell
counts of the CSF and pleural fluid analyses, a sample of
pleural fluid was sent for b2-transferrin assay and was
Figure 1.
Anteroposterior radiograph demonstrating a moderate to
large right-sided pleural fluid collection which is
predominantly subpulmonic in location.
Figure 2.
Right lateral decubitus radiograph demonstrating a moderate
to large right-sided pleural fluid collection which is
predominantly subpulmonic in location.
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shunt was externalized followed by a dramatic decrease in
chest tube drainage. A repeat chest radiograph revealed
resolution of the pleural fluid collection and the chest tube
was removed. The patient’s abdominal girth decreased
and a repeat abdominal/pelvic ultrasound demonstrated
resolution of ascites. The patient’s externalized ventricular
drain was subsequently converted to a ventriculoarterial
shunt.
Discussion
We report the use of b2-transferrin for the diagnosis of CSF
hydrothorax in a child with a transudative pleural
effusion. Although used previously in other applications,
to the best of our knowledge, this is the first reported use
of b2-transferrin to detect a CSF pleural effusion in a child
with a VP shunt.
A variety of techniques to investigate ascites and/or pleural
effusion in patients with VP shunts have been reported in
the literature. Among the described methods is the use of
radiopaque contrast. This particular procedure involves
the injection of radioactive dye at a point along the shunt
pathway followed by subsequent imaging studies to trace
the migration of contrast-injected CSF [4]. An alternative
diagnostic strategy in cases of CSF ascites or hydrothorax
involves repositioning of the distal shunt, usually through
relocation of the cathetertip within the peritonealcavity or
into the right atrium, with subsequent resolution of CSF
fluid collections [5].
A novel diagnostic strategy was utilized in the case of our
patient. A sample of fluid, drained via tube thoracostomy,
was sent for beta-2-transferrin level. This desialated
isoform of transferrin is almost exclusively found in the
CSF with only minimal amounts present in cochlear
perilymph and in the aqueous and vitreous humor of the
eye. Multiple studies have validated the use of beta-2-
transferrin as a specific marker for CSF leakage with
sensitivity and specificity approaching 100% and 95%,
respectively [6]. Furthermore, Huggins and Sahn (2003)
report the use of beta-2-transferrin to identify the presence
of a CSF pleural effusion in an elderly patient with a duro-
pleural fistula [7]. To our knowledge, however, beta-2-
transferrin has never been previously utilized to identity
CSF hydrothorax in children with VP shunts.
Following externalization of the distal VP tip, our patient’s
ascites and pleural effusion promptly resolved. This
finding, in combination with a positive beta-2-transferrin
assay, was highly suggestive of a CSF hydrothorax.
The findings of CSF hydrothorax and ascites, as demon-
strated in our patient, are rare complications of VP shunts.
Reported to occur anywhere from days to years post-
operatively, CSF ascites usually develops within the first 2
years after VP shunt placement [8]. In greater than 50% of
these cases, clinical and/or laboratory investigations fail to
reveal anunderlying abdominal orother disease process to
account for CSF ascites [9].
We propose a pathological intraperitoneal process, such as
subclinical peritonitis, to account for the development of
CSF ascites in our patient. Inflammation of the peritoneal
membrane may lead to intraperitoneal accumulation of
fluid through theimpairment of lymphatic flow[9] and/or
by increasing intra-abdominal pressure and volume [10].
As evidence to date suggests that modern shunt materials
are inert, alternative sources of peritoneal irritation need to
be considered. For example, an immune reaction to a
foreign protein such as a vaccine may be enough to
precipitate ascites in patients with VP shunts [5]. As the
timing of our patient’s most recent immunization in
relation to his presentation is unknown, this possibility
cannot be eliminated. Furthermore, although our patient’s
CSF and pleural fluid cultures were sterile, it is not possible
to definitely refute the presence of an infectious process.
For example, a subclinical viral infection may have been
sufficient to cause peritoneal inflammation in our patient
with resultant CSF ascites [11]. Furthermore, a strength-
ened immune response in infants, coupled with age-
related decreased peritoneal absorptive capacity, makes
subclinical peritonitis an important consideration in our
patient [8].
Alternative explanations for CSF ascites in the literature
such as excess CSF production, surgical procedures, and
high CSF protein are less plausible explanations for our
patient’s CSF ascites. Firstly, it has been suggested that CSF
ascites can result from excessive CSF production, with the
excess fluid overwhelming the absorptive capacity of the
peritoneum [12]. Despite an undiagnosed etiology for
hydrocephalus in our patient, the absence of an interval
Table 1. Pleural and cerebrospinal fluid analysis
Biochemical
measure
Pleural fluid Cerebrospinal
fluid
Glucose 5.1g/L 4.1g/L
Total protein ≤10g/L <0.1g/L
Triglyceride <0.11g/L
White blood
count
440 38
Red blood
count
20 0
Lymphocytes 50 56
Mesothelial
cells
13
Gram stain &
culture
No organisms
seen; sterile fluid
No organisms
seen; sterile fluid
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an unlikely precipitant for his ascites. Secondly, a history
of shunt revision or previous abdominal surgery has also
been reported in patients with CSF ascites [5]. Although
our patient underwent a shunt surgery two and a half
months before presentation, there was no history of shunt
revisions or abdominal surgeries.
Lastly, high CSF protein has been proposed as a potential
cause of CSF ascites [9]. According to this supposition, an
elevated CSF protein content may lead to reversed osmosis
at the level of the blood–brain barrier with the resultant
accumulation of excessive CSF fluid within the peritoneal
cavity [13]. However, numerous cases of high CSF protein
without resultant ascites have been reported [9]. Further-
more, as demonstrated in a previous case report, CSF
ascites can occur despite normal levels of protein in the
CSF [10].
The finding of CSF ascites in our patient can be used to
explain the coincident finding of pleural effusion. Taub
and Lavyne (2004) suggest three mechanisms to account
for the development of CSF hydrothorax post-VP shunt
placement [3]. Firstly, they propose that an error in
surgical shunt placement, with resultant intrathoracic
trauma, may account for some cases of CSF hydrothorax.
Secondly, Taub and Lavyne suggest that pleural effusion
may develop secondary to supra- or trans-diaphragmatic
migration of the shunt tip into the thorax.
Considering that no surgical complications during VP
shunt placement were reported in our patient and that his
shunt series at the time of admission was normal, an
alternative explanation is required. Thus, it is the third
mechanism proposed by Taub and Lavyne, the develop-
ment of hydrothorax secondary to CSF ascites that offers
the most promising explanation for our patient’s pleural
effusion [3].
In order for CSF ascites to result in pleural effusion, some
degree of open communication must exist between the
peritoneal cavity and the pleural space. Congenital
diaphragmatic defects or weak points in the diaphragm
such as the Foramen of Morgagni or Foramen of
Bochdalek provide potential conduits. Furthermore, one
or more microscopic diaphragmatic communications is
likely to be sufficient for the transdiaphragmatic move-
ment of peritoneal fluid [2]. These posited congenital or
acquired fenestrations enable peritoneal fluid to pass into
the pleural space along a unidirectional pressure gradient
[14]. This posited pressure differential results from a cyclic
negative intrathoracic pressure, created during inspiration,
coupled with increased hydrostatic intra-abdominal pres-
sure [2]. In addition to causing a build-up of ascitic fluid,
sub-clinical inflammation likely contributes to this process
by facilitating the transudation of fluid through diaphrag-
matic capillary and lymphatic channels [4]. Fluid subse-
quently accumulates inthepleural space secondary to high
volume transdiaphragmatic flow and the overwhelming of
pleural absorptive abilities [14]. As the pleural surface
remains pathology free with its sieve characteristics
consequently intact, the cell and protein content of the
ensuing pleural effusion should remain low [15]. These
pleural fluid characteristics, along with a predominance of
lymphocytes and mesothelial cells, suggest a transudative
pleural effusion.
Although no gross diaphragmatic defect was identified in
our patient, the presence of microscopic diaphragmatic
communications may have been present. Notably, the
tapped pleural fluid characteristics of our patient were
found to be in keeping with a transudative effusion. The
collected pleural fluid also demonstrated a marginally
higher protein concentration than in the patient’s CSF
fluid. Differences in the solute composition of ventricular-
extracted CSF and pleural fluid have been previously
demonstrated in patients with pleural effusion secondary
to VP shunts [2]. The finding of a slightly higher protein
concentration in the pleural verses peritoneal fluid, the
latter having been derived from CSF, can be explained by
the preferential absorption of water over protein across the
visceral pleura [15]. With this in mind, inconsistent solute
characteristics, such as protein concentration, between
pleural effusion and pure CSF should not be used to refute
the possibility of CSF hydrothorax in patients with VP
shunts.
Conclusion
In summary, we present the case of a 14-month-old boy
with CSF hydrothorax secondary to VP shunt. Pleural
effusion following VP shunt insertion is a rare and
potentially life-threatening event and hence requires
prompt diagnosis and correction. We report a novel and
non-invasive technique by which to identify the presence
of CSF in pleural fluid. Beta-2-transferrin assay may serve
as a useful new means for the identification of CSF
hydrothorax in the context of patients with VP shunts.
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